Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions
Deqing Sun,1,2 Xinbing Wei,1 Xia Xue,2 Zengjun Fang,3 Manru Ren,1 Haiyan Lou,1 Xiumei Zhang11Department of Pharmacology, School of Medicine, Shandong University, Jinan, People’s Republic of China; 2Department of Pharmacy, 3Department of Clinical Pharmacology, Second Hospital of Shandong U...
Guardado en:
| Autores principales: | , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/2c54cf509e804a14ba0561e02c089cf3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:2c54cf509e804a14ba0561e02c089cf3 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:2c54cf509e804a14ba0561e02c089cf32021-12-02T00:36:36ZEnhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions1178-2013https://doaj.org/article/2c54cf509e804a14ba0561e02c089cf32014-07-01T00:00:00Zhttp://www.dovepress.com/enhanced-oral-absorption-and-therapeutic-effect-of-acetylpuerarin-base-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013 Deqing Sun,1,2 Xinbing Wei,1 Xia Xue,2 Zengjun Fang,3 Manru Ren,1 Haiyan Lou,1 Xiumei Zhang11Department of Pharmacology, School of Medicine, Shandong University, Jinan, People’s Republic of China; 2Department of Pharmacy, 3Department of Clinical Pharmacology, Second Hospital of Shandong University, Jinan, People’s Republic of ChinaBackground: Acetylpuerarin (AP), because of its lower water solubility, shows poor absorption that hinders its therapeutic application. Thus, the aim of this study was to prepare nanoemulsions for AP, enhance its oral bioavailability, and thus improve the therapeutic effect.Methods: The nanoemulsions stabilized by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) were prepared by high-pressure homogenization and characterized in terms of particle size, drug loading, morphology, and in vitro drug release. A lipid digestion model was used to predict in vivo drug solubilization in the gastrointestinal environment. The pharmacokinetics of AP formulations were performed in rats; meanwhile, a chylomicron flow-blocking rat model was used to evaluate the lymphatic drug transport. Moreover, the therapeutic effects of AP nanoemulsions on the model of focal cerebral ischemia-reperfusion for brain injury were also assessed.Results: The nanoemulsions with a droplet size of 150 nm were well stabilized by TPGS and showed a high loading capacity for AP. In the digestion model, the distribution of AP in aqueous phase/pellet phase was about 90%/10% for nanoemulsions and 5%/95% for oil solution, indicating that the drug encapsulated in nanoemulsions would present in solubilized form after transportation into the gastrointestinal tract, whereas drug precipitation would occur as the oil solution was orally administered. The area under the curve value of AP nanoemulsions was 5.76±0.56 µg·hour·mL-1, or was about 2.6 and 1.7 times as great as that of suspension and oil solution, respectively, indicating enhanced drug absorption and thus achieving a better neuroprotection effect on cerebral ischemic reperfusion injury. The values of peak plasma concentration and area under the curve from the blocking model were significantly less than those of the control model, suggesting that the lymphatic transport performed a very important role in absorption enhancement.Conclusion: Enhanced oral bioavailability in nanoemulsions was achieved via the mechanism of the maintenance of drug solubilization in the gastrointestinal tract and the enhancement of lymphatic transport, which resulted in therapeutic improvement of cerebral ischemic reperfusion injury.Keywords: absorption, nanoemulsions, TPGS, lipid digestion, lymphatic transport, chylomicron flow-blocking rat model, transient middle cerebral artery occlusion rat modelSun DQWei XBXue XFang ZJRen MRLou HYZhang XMDove Medical PressarticleMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol 2014, Iss Issue 1, Pp 3413-3423 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine (General) R5-920 |
| spellingShingle |
Medicine (General) R5-920 Sun DQ Wei XB Xue X Fang ZJ Ren MR Lou HY Zhang XM Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions |
| description |
Deqing Sun,1,2 Xinbing Wei,1 Xia Xue,2 Zengjun Fang,3 Manru Ren,1 Haiyan Lou,1 Xiumei Zhang11Department of Pharmacology, School of Medicine, Shandong University, Jinan, People’s Republic of China; 2Department of Pharmacy, 3Department of Clinical Pharmacology, Second Hospital of Shandong University, Jinan, People’s Republic of ChinaBackground: Acetylpuerarin (AP), because of its lower water solubility, shows poor absorption that hinders its therapeutic application. Thus, the aim of this study was to prepare nanoemulsions for AP, enhance its oral bioavailability, and thus improve the therapeutic effect.Methods: The nanoemulsions stabilized by D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) were prepared by high-pressure homogenization and characterized in terms of particle size, drug loading, morphology, and in vitro drug release. A lipid digestion model was used to predict in vivo drug solubilization in the gastrointestinal environment. The pharmacokinetics of AP formulations were performed in rats; meanwhile, a chylomicron flow-blocking rat model was used to evaluate the lymphatic drug transport. Moreover, the therapeutic effects of AP nanoemulsions on the model of focal cerebral ischemia-reperfusion for brain injury were also assessed.Results: The nanoemulsions with a droplet size of 150 nm were well stabilized by TPGS and showed a high loading capacity for AP. In the digestion model, the distribution of AP in aqueous phase/pellet phase was about 90%/10% for nanoemulsions and 5%/95% for oil solution, indicating that the drug encapsulated in nanoemulsions would present in solubilized form after transportation into the gastrointestinal tract, whereas drug precipitation would occur as the oil solution was orally administered. The area under the curve value of AP nanoemulsions was 5.76±0.56 µg·hour·mL-1, or was about 2.6 and 1.7 times as great as that of suspension and oil solution, respectively, indicating enhanced drug absorption and thus achieving a better neuroprotection effect on cerebral ischemic reperfusion injury. The values of peak plasma concentration and area under the curve from the blocking model were significantly less than those of the control model, suggesting that the lymphatic transport performed a very important role in absorption enhancement.Conclusion: Enhanced oral bioavailability in nanoemulsions was achieved via the mechanism of the maintenance of drug solubilization in the gastrointestinal tract and the enhancement of lymphatic transport, which resulted in therapeutic improvement of cerebral ischemic reperfusion injury.Keywords: absorption, nanoemulsions, TPGS, lipid digestion, lymphatic transport, chylomicron flow-blocking rat model, transient middle cerebral artery occlusion rat model |
| format |
article |
| author |
Sun DQ Wei XB Xue X Fang ZJ Ren MR Lou HY Zhang XM |
| author_facet |
Sun DQ Wei XB Xue X Fang ZJ Ren MR Lou HY Zhang XM |
| author_sort |
Sun DQ |
| title |
Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions |
| title_short |
Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions |
| title_full |
Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions |
| title_fullStr |
Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions |
| title_full_unstemmed |
Enhanced oral absorption and therapeutic effect of acetylpuerarin based on D-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions |
| title_sort |
enhanced oral absorption and therapeutic effect of acetylpuerarin based on d-α-tocopheryl polyethylene glycol 1000 succinate nanoemulsions |
| publisher |
Dove Medical Press |
| publishDate |
2014 |
| url |
https://doaj.org/article/2c54cf509e804a14ba0561e02c089cf3 |
| work_keys_str_mv |
AT sundq enhancedoralabsorptionandtherapeuticeffectofacetylpuerarinbasedondalphatocopherylpolyethyleneglycol1000succinatenanoemulsions AT weixb enhancedoralabsorptionandtherapeuticeffectofacetylpuerarinbasedondalphatocopherylpolyethyleneglycol1000succinatenanoemulsions AT xuex enhancedoralabsorptionandtherapeuticeffectofacetylpuerarinbasedondalphatocopherylpolyethyleneglycol1000succinatenanoemulsions AT fangzj enhancedoralabsorptionandtherapeuticeffectofacetylpuerarinbasedondalphatocopherylpolyethyleneglycol1000succinatenanoemulsions AT renmr enhancedoralabsorptionandtherapeuticeffectofacetylpuerarinbasedondalphatocopherylpolyethyleneglycol1000succinatenanoemulsions AT louhy enhancedoralabsorptionandtherapeuticeffectofacetylpuerarinbasedondalphatocopherylpolyethyleneglycol1000succinatenanoemulsions AT zhangxm enhancedoralabsorptionandtherapeuticeffectofacetylpuerarinbasedondalphatocopherylpolyethyleneglycol1000succinatenanoemulsions |
| _version_ |
1718403605306802176 |